Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 2 | 102337157 | 5 prime UTR variant | G/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.820 | 1.000 | 4 | 2011 | 2019 | ||||||||
|
0.925 | 0.120 | 2 | 102350089 | intron variant | A/G | snv | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.810 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.882 | 0.080 | 2 | 102319699 | intron variant | T/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 3 | 2018 | 2019 | ||||||||
|
0.882 | 0.160 | 2 | 102349850 | intron variant | G/A | snv | 0.33 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2016 | 2019 | |||||||
|
1.000 | 0.080 | 2 | 102338622 | intron variant | G/A | snv | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.810 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.925 | 0.160 | 2 | 102338193 | 5 prime UTR variant | C/T | snv | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2010 | 2011 | |||||||
|
0.882 | 0.080 | 2 | 102319699 | intron variant | T/A;C | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2019 | 2019 | ||||||||
|
1.000 | 0.120 | 2 | 102316052 | intron variant | G/A;T | snv |
|
Immune System Diseases | 0.800 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
1.000 | 0.080 | 2 | 102340888 | intron variant | C/T | snv | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 2 | 102340888 | intron variant | C/T | snv | 0.18 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.120 | 2 | 102350089 | intron variant | A/G | snv | 0.18 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 2 | 102350089 | intron variant | A/G | snv | 0.18 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.160 | 2 | 102349850 | intron variant | G/A | snv | 0.33 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.882 | 0.160 | 2 | 102349850 | intron variant | G/A | snv | 0.33 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.160 | 2 | 102349850 | intron variant | G/A | snv | 0.33 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
2 | 102324851 | intron variant | G/A | snv | 0.18 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
2 | 102351384 | intron variant | C/A;G | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
2 | 102324878 | intron variant | T/C | snv | 0.66 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.925 | 0.040 | 2 | 102310521 | upstream gene variant | G/A | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.040 | 2 | 102310521 | upstream gene variant | G/A | snv | 0.54 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
2 | 102349411 | intron variant | C/T | snv | 0.22 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
0.925 | 0.080 | 2 | 102309902 | upstream gene variant | G/A | snv | 0.30 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 2 | 102309902 | upstream gene variant | G/A | snv | 0.30 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 2 | 102309902 | upstream gene variant | G/A | snv | 0.30 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 2 | 102309902 | upstream gene variant | G/A | snv | 0.30 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |